"I think every client I've ever had has tried to think of ways to extend the monopoly they've enjoyed."
– Edmund Pitcher, patent attorney
"There is no reason, I think, [for biotechs] to feel threatened as assets tend to spend the 'internship' years with biotechs. Great things graduate from academic institutions, but new graduates are seldom ready for real life."
– Jeff Stewart, director of Raleigh, N.C.-based biopharma consultant Campbell Alliance, discussing the trend toward partnering between academia and big pharma
"This doesn't feel like an IPO window, more like a 'crack in the door.'"
– Ali Behbahani, principal, New Enterprise Associates